XX-650-23, a small molecule inhibitor of CREB, specifically disrupts the interaction of CREB to the KIX domain of CREBBP and inhibits CREB-driven gene expression in AML cells, further promoting apoptosis and cell cycle arrest and prolonging survival in mice injected with human AML cells [130]. This evidence concerns the gene CREB1 and acute myeloid leukemia.